http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-9306006-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e1c56b88229114d57f1a0050eb922f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
filingDate 1993-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77edfae671ea76dc074a7ed923f9d9e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07540d6f4a2e5395929c3064e6a40d40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f21cb01932ecf54e1720cc38e066e9fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_579a9266bc838cf9a079395d3925b7e9
publicationDate 1995-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-9306006-A
titleOfInvention ANTAGONIST COMBINATIONS IBUPROFEN-H2.
abstract This invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation and in the relief of indigestion, acid stomach, heartburn, and other gastrointestinal disorders in mammals including humans when administering compositions comprising (i) an effective amount. analgesically and anti-inflammatory of a salt of ibuprofen (s) basically free of ibuprofen (R) where the salt is selected from (s) ibuprofen- (s) -lysine and (s) -ibuprofen- (R) -lysine; and (ii) a deficient amount in the relief of acid stomach indigestion, heartburn, overeating, and other gastro-intestinal disorders of at least one of the H2 antagonists.
priorityDate 1992-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449649464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15009331

Total number of triples: 30.